Sign in
WithdrawnPhase 4

Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia

Key facts

Who runs it
McGill University Health Centre/Research Institute of the McGill University Health Centre
Where
Canada1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Phase
Phase 4
Started
Dec 2013
Ended
Apr 2024
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Travasol (amino acid injection)
  • Insulin
Record updated
8 October 2026
Why it stopped
organisational problems

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • American Society of Anesthesiologists class<3
  • age>18 years
  • colorectal surgery for non-metastatic colorectal adenocarcinoma including right and left hemicolectomy, transverse, subtotal and total colectomy sigmoid and low anterior resection
  • ability to give informed consent

Who cannot take part

  • significant cardiorespiratory, hepatic, renal and neurological disease
  • musculoskeletal or neuromuscular disease
  • history of severe sciatica, back surgery or other conditions which contraindicate the use of epidural catheters
  • confirmed diagnosis of diabetes mellitus or a HbA1c>6.0%
  • ingestion of drugs known to affect protein, glucose and lipid metabolism (e.g. steroids)
  • severe anemia (hemoglobin<10 g/dL
  • BMI>30 Kg/meter squared
  • pregnancy

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this study is to find out whether adding insulin after current colorectal cancer surgery promotes making and keeping proteins in the body, and to find out whether or not this effect can be further increased by increasing the amount of protein given.

The 3 groups in the trial

  • Insulin, Travasol (35%) postopTreatment being tested

    Insulin (hyperinsulinemic-normoglycemic clamp) with Travasol (amino acid supplementation) given from start of surgery to 6 hours after, at an amount of 35% of patient's energy expenditure as measured before surgery, .

    Treatment: Travasol (amino acid injection) and Insulin

  • Insulin, Travasol (20%) postopTreatment being tested

    Insulin (hyperinsulinemic-normoglycemic clamp) with Travasol (amino acid infusion), given from start of surgery to 6 hours after, at an amount of 20% of patient's energy expenditure as measured before surgery.

    Treatment: Travasol (amino acid injection) and Insulin

  • Insulin, no protein after surgeryPlacebo, for comparison

    Insulin (hyperinsulinemic-normoglycemic clamp, an insulin infusion between 2 and 5 microunits/kg with glucose at a variable rated titrated to maintain normoglycemia, blood glucose 4-6 mmol/L) with no protein supplementation from start of surgery to 6 hours after.

    Treatment: Insulin

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
8 October 2026